Where is the peer-reviewed study? Things like Bell's palsy usually come after some sort of adverse event, such as vaccination. In all Big-Pharma sponsored vaccine studies to date, unvaccinated are never a control group. Because when the unvaccinated are a control group, their adverse effects are greatly reduced compared to the vaccinated (as demonstrated by the study I posted previously).
As a result, Big-Pharma funded studies compare those vaccinated with one vaccine, against those vaccinated with another vaccine. If this is true of the coronavirus vaccine, it means that it is probably at least 3 times more likely to cause Bell's palsy than the other vaccine used as the "control", which would explain that more people are noticing the adverse outcomes.
So called "fact-checkers" trying to explain this story away are just wrong. If the incidence of Bell's palsy is 23 per 100,000 per annum ("fact-checker" upper estimate), and there were 38,000 human guinea-pigs in the covid vaccine trial for 60 days, the expected incidence rate of Bell's palsy would be less than 1.44 human guinea-pigs suffering the disease during the trial duration. So an incident rate of 4 in the guinea-pigs is more than 250% of the population average (and note that the population average is still skewed high as people in the population routinely receive vaccines, artificially increasing the presumed incidence of the disease for those people who do not accept vaccinations).
FDA: Track Vaccine Recipients for Facial Paralysis
By Carolyn Crist
December 17, 2020 -- The FDA
issued a staff report on Tuesday that recommends monitoring people who take the Pfizer and Moderna COVID-19 vaccines for potential cases of Bell’s palsy, or facial paralysis.
The condition isn’t considered a side effect of the vaccines, the staff wrote, but they plan to track the data on vaccine recipients to spot any potential cases.
The report said 4 of 30,000 participants in the Moderna clinical trial had Bell’s palsy, including 3 participants who received the vaccine instead of the placebo. Similarly, 4 out of 43,000 participants in the Pfizer clinical trial had Bell’s palsy, and all 4 received the vaccine.
The paralysis occurred between 22 days and 32 days after the shot, the FDA staff said. Two of the Bell’s palsy cases in the Moderna trial have resolved. The staff has endorsed both of the COVID-19 vaccines and said there’s not enough data to show whether the cases were tied directly to the vaccines, according
to CNBC.
“There were no other notable patterns or numerical imbalances between treatment groups for specific categories of adverse events, including other neurologic, neuro-inflammatory, and thrombotic events, that would suggest a causal relationship to the Moderna COVID-19 vaccine,” the staff wrote.
Importantly, the rate of Bell’s palsy in the clinical trials is lower than the overall rate in the general population, they wrote. About 35 per 100,000 people get Bell’s palsy in the U.S. each year, according
to the National Organization for Rare Disorders, and about 40,000 Americans are diagnosed annually.
The exact cause of the condition isn’t known, but it’s typically associated with a viral infection, immune disorder or inflammation in the nerve that controls facial muscles, NORD said.
“It’s a relatively benign condition,” Anthony Geraci, MD, the director of neuromuscular medicine at Northwell Health in New York,
told USA Today.
Geraci sees at least two patients per month with Bell’s palsy, and they tend to recover in several weeks, he said. Severe or permanent conditions are extremely rare, he added, and encouraged people to not let the report prevent them from getting a COVID-19 vaccine.
“It’s a cautionary tale that should not mitigate the larger good that both individuals and society are going to derive from all of these vaccines,” he said.
The CDC said last week that it would monitor vaccine recipients for Bell’s palsy but said the COVID-19 vaccines don’t appear to cause the condition, according
to CNBC. The FDA will also track data on facial paralysis cases as vaccines are administered to patients.
“Our working hypothesis is this just was an imbalance in background rates like we’ve seen in other trials, but we’ll make sure that we’re going to actually query for that just to bring that question to close,” Peter Marks, MD, director of the FDA’s Center for Biologics Evaluation and Research, said in an
interview with JAMA on Monday.
Some anti-vaccination groups have used the Bell’s palsy cases to question the safety of the vaccines,
Reuters reported. But the FDA and CDC, as well as independent experts, have all said there is no reason to be alarmed by the handful of cases.
WebMD Health News Brief